163 related articles for article (PubMed ID: 38008721)
1. Prognostic potential of whole exome sequencing in the clinical management of metachronous colorectal cancer liver metastases.
Heczko L; Hlaváč V; Holý P; Dvořák P; Liška V; Vyčítal O; Fiala O; Souček P
Cancer Cell Int; 2023 Nov; 23(1):295. PubMed ID: 38008721
[TBL] [Abstract][Full Text] [Related]
2. Exome Sequencing of Paired Colorectal Carcinomas and Synchronous Liver Metastases for Prognosis and Therapy Prediction.
Hlaváč V; Červenková L; Šůsová S; Holý P; Liška V; Vyčítal O; Šorejs O; Fiala O; Daum O; Souček P
JCO Precis Oncol; 2023 May; 7():e2200557. PubMed ID: 37141551
[TBL] [Abstract][Full Text] [Related]
3. Comparative genomic analysis of primary and synchronous metastatic colorectal cancers.
Lee SY; Haq F; Kim D; Jun C; Jo HJ; Ahn SM; Lee WS
PLoS One; 2014; 9(3):e90459. PubMed ID: 24599305
[TBL] [Abstract][Full Text] [Related]
4. Utility of exome sequencing in routine care for metastatic colorectal cancer.
D'Agay MG; Galland L; Tharin Z; Truntzer C; Ghiringhelli F
Mol Clin Oncol; 2021 Nov; 15(5):229. PubMed ID: 34631054
[TBL] [Abstract][Full Text] [Related]
5. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
[TBL] [Abstract][Full Text] [Related]
6. Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.
Mogensen MB; Rossing M; Østrup O; Larsen PN; Heiberg Engel PJ; Jørgensen LN; Hogdall EV; Eriksen J; Ibsen P; Jess P; Grauslund M; Nielsen HJ; Nielsen FC; Vainer B; Osterlind K
BMC Cancer; 2018 Jul; 18(1):752. PubMed ID: 30029640
[TBL] [Abstract][Full Text] [Related]
7. Genomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal Cancer.
Kawaguchi Y; Kopetz S; Kwong L; Xiao L; Morris JS; Tran Cao HS; Tzeng CD; Chun YS; Lee JE; Vauthey JN
J Am Coll Surg; 2021 Aug; 233(2):272-284.e13. PubMed ID: 34111531
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
[TBL] [Abstract][Full Text] [Related]
9. Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.
Buckley AR; Ideker T; Carter H; Harismendy O; Schork NJ
Genome Med; 2018 Sep; 10(1):69. PubMed ID: 30217226
[TBL] [Abstract][Full Text] [Related]
10. Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers.
Robles AI; Traverso G; Zhang M; Roberts NJ; Khan MA; Joseph C; Lauwers GY; Selaru FM; Popoli M; Pittman ME; Ke X; Hruban RH; Meltzer SJ; Kinzler KW; Vogelstein B; Harris CC; Papadopoulos N
Gastroenterology; 2016 Apr; 150(4):931-43. PubMed ID: 26764183
[TBL] [Abstract][Full Text] [Related]
11. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability.
Umeda Y; Nagasaka T; Mori Y; Sadamori H; Sun DS; Shinoura S; Yoshida R; Satoh D; Nobuoka D; Utsumi M; Yoshida K; Yagi T; Fujiwara T
J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):223-33. PubMed ID: 23010994
[TBL] [Abstract][Full Text] [Related]
12. The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer.
Huang CW; Tsai HL; Chen YT; Huang CM; Ma CJ; Lu CY; Kuo CH; Wu DC; Chai CY; Wang JY
BMC Cancer; 2013 Dec; 13():599. PubMed ID: 24330663
[TBL] [Abstract][Full Text] [Related]
13. Whole-Exome Sequencing Characterized the Landscape of Somatic Mutations and Pathways in Colorectal Cancer Liver Metastasis.
Feng L; Hong S; Gao J; Li J
J Oncol; 2019; 2019():2684075. PubMed ID: 31814826
[TBL] [Abstract][Full Text] [Related]
14. Genomic and prognostic heterogeneity among RAS/BRAF
Berg KCG; Brunsell TH; Sveen A; Alagaratnam S; Bjørnslett M; Hektoen M; Brudvik KW; Røsok BI; Bjørnbeth BA; Nesbakken A; Lothe RA
Mol Oncol; 2021 Apr; 15(4):830-845. PubMed ID: 33325154
[TBL] [Abstract][Full Text] [Related]
15. Histologic features and genomic alterations of primary colorectal adenocarcinoma predict growth patterns of liver metastasis.
Wu JB; Sarmiento AL; Fiset PO; Lazaris A; Metrakos P; Petrillo S; Gao ZH
World J Gastroenterol; 2019 Jul; 25(26):3408-3425. PubMed ID: 31341365
[TBL] [Abstract][Full Text] [Related]
16. Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity.
Kim TM; Jung SH; An CH; Lee SH; Baek IP; Kim MS; Park SW; Rhee JK; Lee SH; Chung YJ
Clin Cancer Res; 2015 Oct; 21(19):4461-72. PubMed ID: 25979483
[TBL] [Abstract][Full Text] [Related]
17. Whole-exome sequencing identifies prognostic mutational signatures in gastric cancer.
Zhu Z; Fu H; Wang S; Yu X; You Q; Shi M; Dai C; Wang G; Cha W; Wang W
Ann Transl Med; 2020 Nov; 8(22):1484. PubMed ID: 33313229
[TBL] [Abstract][Full Text] [Related]
18. Paired Primary and Metastatic Tumor Analysis of Somatic Mutations in Synchronous and Metachronous Colorectal Cancer.
Kim KP; Kim JE; Hong YS; Ahn SM; Chun SM; Hong SM; Jang SJ; Yu CS; Kim JC; Kim TW
Cancer Res Treat; 2017 Jan; 49(1):161-167. PubMed ID: 27384156
[TBL] [Abstract][Full Text] [Related]
19. Molecular Profiling Provides Clinical Insights Into Targeted and Immunotherapies as Well as Colorectal Cancer Prognosis.
Guo L; Wang Y; Yang W; Wang C; Guo T; Yang J; Shao Z; Cai G; Cai S; Zhang L; Hu X; Xu Y
Gastroenterology; 2023 Aug; 165(2):414-428.e7. PubMed ID: 37146911
[TBL] [Abstract][Full Text] [Related]
20. Delineating the intra-patient heterogeneity of molecular alterations in treatment-naïve colorectal cancer with peritoneal carcinomatosis.
Siesing C; Petersson A; Ulfarsdottir T; Chattopadhyay S; Nodin B; Eberhard J; Brändstedt J; Syk I; Gisselsson D; Jirström K
Mod Pathol; 2022 Jul; 35(7):979-988. PubMed ID: 35169225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
